This 7% Dividend ETF Has Huge Risks
A dividend that big will get you a lot of income on a relatively small investment…
recent post
-
Dec 16 2025 -
Dec 16 2025
-
Dec 16 2025
-
Dec 16 2025
-
Dec 16 2025
Jeremy Grantham’s GMO says stocks are overvalued by every metric, but there are 3 strategies investors can use to weather a crash
“U.S. stock valuations, by almost any backward or forward-looking measure, are at levels that concern us,” said GMO in
These 2 Stocks Seem Fairly Valued Now, but They Could Look Like Bargains in the Future
Callaway and Corsair have great long-term growth prospects.
This Under-the-Radar Pot Stock Is Showing Signs of Life
One quarter of better-than-expected revenue may not be enough.
Wall Street Breakfast: What Moved Markets
Listen on the go! A daily podcast of Wall Street Breakfast’s Alpha Talks will be available this morning on
Better Pot Stock: Canopy Growth vs. Aurora Cannabis
One of these two pot stocks is capable of turning around its fate soon.
Prothena: Underrated Player In Alzheimer’s And Parkinson’s Close To Securing First Drug Approval
Prothena is a biotech with a unique, epitope targeting approach to drug development. It could earn billions in milestone
Large shareholder group calls for a board overhaul at pharma company CytoDyn
Paul Rosenbaum, CEO of SWR Corp., is no stranger to shareholder activism. He’s leading a group of investors calling
Morgan Stanley names 26 stocks outside the tech and media industries that have delivered market-beating growth in recent years — and look poised to continue that expansion in the future
Summary List PlacementGrowth stocks are back in fashion after lagging their value counterparts to start the year. In early 2021…
Better Buy: Invesco QQQ or Fidelity MSCI IT Index ETF
Both of these exchange-traded funds are among the best in their tech-focused class.